Should I Buy Perrigo Company plc (PRGO)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish...
Posts Tagged ‘NYSE:PRGO’
Should Value Investors Buy Perrigo (PRGO) Stock?
First Eagle Investment Management recently released its Q1 2020 Investor Letter, a copy of which you can download below. The First Eagle Fund of America...
Is Perrigo Company (PRGO) A Good Stock To Buy?
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted...
Hedge Funds Are Betting On Perrigo Company plc (PRGO)
Is Perrigo Company plc (NYSE:PRGO) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company...
Here’s What Hedge Funds Think About Perrigo Company plc (PRGO)
Is Perrigo Company plc (NYSE:PRGO) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research. We do so because...
Is Perrigo Company plc (PRGO) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
Hedge Funds Are Selling Perrigo Company plc (PRGO)
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse...
Perrigo Company PLC (PRGO) Becomes The Latest Pharma Investigated Over Price Fixing
The prices of Perrigo Company plc Ordinary Shares (NYSE:PRGO) drugs used in skin treatments is being examined by law enforcement authorities. This is...
Perrigo Company PLC (PRGO) Drug Gets FDA Approval
The Food and Drug Administration has granted final approval to Axiron Topical Solution, a drug manufactured by Perrigo Company plc Ordinary Shares (NYSE...
Perrigo Company PLC (PRGO) Sells Rights To Tysabri
The royalty stream that Perrigo Company plc Ordinary Shares (NYSE:PRGO) used to get from Tysabri has been sold to Royalty Pharma. Both companies are based...
Five Companies to Benefit from Activist Starboard Value’s Involvement in 2017
Jeffrey Smith‘s Starboard Value, one of the biggest and most famous activist hedge funds, has recently filed its 13F, in which it reported an equity...
Why Perrigo Company & Four Other Stocks Are Making Headlines on Wednesday
The latest EIA numbers are in, and as expected, the report contradicted yesterday’s bearish API build data. Domestic production fell by 29,000...
4 Long Ideas From the London Value Investor Conference
Insider Monkey readers and other stock market participants are surely on the lookout for good investment ideas at all times. Indeed, there is no easy...
Why These 5 Stocks Are Making Headlines on Monday
It’s the beginning of another big trading week, and the Dow Jones and S&P 500 are below the key technical points of 18,000 and 21,000, respectively...
A Look at Seneca Capital’s Final Top Stock Picks
2015 was a disappointing year for the hedge fund industry with several funds closing and returning money to their investors. At the end of December,...
Visium Asset Management Is a Staunch Supporter of These 5 Healthcare Stocks
Jacob Gottlieb’s Visium Asset Management recently filed its latest 13F with the Securities and Exchange Commission for the reporting period of September...
More and More Hedge Funds Are Selling Perrigo Company plc (PRGO)
How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly-traded companies. However...
Billionaire James Dinan Loaded Up On These Stocks For Q4
York Capital Management is a New York-based long/short equity hedge fund founded by billionaire James Dinan. Mr. Dinan worked as an investment banker...
Why These Stocks Are Tanking Today
The decline of the U.S. stocks is continuing for the third day straight, after disappointing economic data put downward pressure on the market. The energy...
These Stocks Are in Spotlight on M&A-Related News
With the stock market losing ground on the back of expectations of a possible interest rate hike by the Fed next month, fueled by strong non-farm payroll...
Hedge Funds Lost $52 Billion On These 25 Stocks
Valeant Pharmaceuticals International (NYSE:VRX) made financial journalists’ day when it cratered following short seller Citron’s hyperbolic...
Five Foreign Stocks To Buy Now
In order to diversify portfolios and reduce exposure to one particular country, it is generally a good idea for retail investors to buy shares of companies...
Billionaires Can’t Live Without These 10 Stocks
At Insider Monkey, we track more than 700 elite hedge funds and use their combined wisdom to identify 15 exceptional small-cap stocks every quarter, which...
Billionaires See A Healthy Future For These Healthcare Stocks
The S&P 500 Health Care Index has advanced by 21.11% over the past three-year period, which is significantly higher than the S&P 500’s return...
Hedge Funds Were Opening Positions in These 5 Healthcare Stocks
Insider Monkey has been keenly following the moves of the more than 700 hedge funds in our database, analyzing the entirety of their submitted 13F filings...
Billionaire James Dinan’s Top New Stock Picks For Q3
Billionaire James Dinan founded York Capital Management, a New York-based long/short equity hedge fund, in 1991. Prior to founding York, Mr. Dinan worked...
Wedgewood Partners’ Investor Letter Dishes On QUALCOMM Inc (QCOM), Perrigo Company (PRGO), More
Wedgewood Partners is a St. Louis-based mutual fund which was founded in 1988 with the goal of providing investors a superior approach to managing their...
History Tells Jacob Gottlieb His Top 3 Large-Cap Positions Beat The Market
Jacob Gottlieb is the manager and founder of Visium Asset Management. The fund was formed back in 2005 in New York, and since then it has raised its assets...
Actavis PLC (ACT), Laboratory Corp. of America Holdings (LH) Among Health Fund Visium’s Top Picks
Visium Asset Management has submitted its 13F filing with the SEC for the reporting period of March 31. The fund was founded in 2005 by Jacob Gottlieb...
Billionaire Ken Griffin’s New Stock Moves
In a 13F filing, Citadel Investment Group, managed by Ken Griffin revealed its holding for the fourth quarter. The value of its equity portfolio has increased...
Omthera Pharmaceuticals Inc (OMTH), Elan Corporation, plc (ADR) (ELN), Onyx Pharmaceuticals, Inc. (ONXX): 3 Big Biotech Buyouts of 2013
The Chinese calendar says 2013 is the year of the snake, but the market says it’s the year of biotech. Major biotechnology ETFs and indices have...
J.C. Penney Company, Inc. (JCP), Perrigo Company (PRGO), Cabot Oil & Gas Corporation (COG): Shorts Are Piling Into These Stocks. Should You Be Worried?
The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long...
Perrigo Company (PRGO): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
Should Perrigo Company (NYSE:PRGO) investors track the following data? In the eyes of many traders, hedge funds are perceived as useless, outdated financial...
Perrigo Company (PRGO), Elan Corporation, plc (ADR) (ELN), Johnson & Johnson (JNJ): Is This Health Care Stock Underrated?
Shares of Perrigo Company (NYSE:PRGO), one of the world’s largest health care suppliers, slid with the broader market on Aug. 15 after the company...
Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Perrigo Company (PRGO): Obamacare and Generic Pharmaceuticals
Will generic pharmaceutical makers like Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Perrigo Company (NYSE:PRGO) continue to be a value...
Perrigo Company (PRGO), Elan Corporation, plc (ADR) (ELN): This Deal Could Shake Up the Generic Drug Business
Many market-watchers are scratching their heads about the pharmaceutical industry’s latest blockbuster deal. Although it had been expected to make...
Perrigo Company (PRGO), Elan Corporation, plc (ADR) (ELN): Will This Be the Next Irish Biotech Acquisition?
Perrigo Company (NYSE:PRGO)’s acquisition of Elan Corporation, plc (ADR) (NYSE:ELN) for $8.6 billion has been widely criticized by many as a way for...
Elan Corporation, plc (ADR) (ELN), Perrigo Company (PRGO): Examining an Acquisition That Benefits This Global Healthcare Supplier
Recently, Elan Corporation, plc (ADR) (NYSE:ELN) ended the fight against bids from Royalty Pharma. Previously, Royalty Pharma had raised its all-cash...
Perrigo Company (PRGO), Elan Corporation, plc (ADR) (ELN): This Merger Adds Value Multiple Ways
2013 is turning out to be a stellar year for Mergers and Acquisitions. There have been a number of M&A deals in healthcare and technology sectors....
Dell Inc. (DELL), Elan Corporation, plc (ADR) (ELN): You’re a Bad Investor. Here’s How to Get Better.
The chances are good that you’re a bad investor. I’m sorry if that comes as an unpleasant surprise, but if you have any doubt about it, I...
Perrigo Company (PRGO), Elan Corporation, plc (ADR) (ELN): Is This Acquisition a Game Changer?
A patented drug is a cash cow for drug manufacturers. There are two ways to have a patented cash generating drug on a pharmaceutical company’s pipeline...
Elan Corporation, plc (ADR) (ELN), Perrigo Company (PRGO): Strange Biotech Bedfellows
When I interviewed Alkermes Plc (NASDAQ:ALKS)‘ CEO Richard Pops last year, he described the relocation of the company’s headquarters to Ireland...
Perrigo Company (PRGO) to Buy Elan Corporation, plc (ADR) (ELN) for $8.6 Billion
After months of fighting off the advances of unwanted suitor Royalty Pharma, Irish biotech Elan Corporation, plc (ADR) (NYSE:ELN) finally got an offer...
Abbott Laboratories (ABT), Merck & Co., Inc. (MRK): The Proprietary Drug Business Just Got Riskier
A new Supreme Court ruling presents pharmaceutical companies with a tough choice — stop paying generic-drug producers to withhold generic options...
